Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
New data on intravascular imaging-guided PCI & pulsed-field ablation | FDA clears AFib-detecting scale
Tuesday, August 29, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

News Alert

Intravascular imaging-guided PCI improves patient outcomes, new meta-analysis confirms

The ILUMIEN IV and OCTOBER trials helped illustrate that the benefits of intravascular ultrasound also are seen with optical coherence tomography. Both trials were included in the new meta-analysis presented at ESC Congress 2023.

READ MORE >
Example of intravascular ultrasound (IVUS) shown as part of the multimodality imaging capability on the Fujifilm CVIS.
Share on Twitter Share on Facebook Share on Linkedin

Intravascular imaging-guided PCI improves patient outcomes, new meta-analysis confirms

Share on Twitter Share on Facebook Share on Linkedin
Example of intravascular ultrasound (IVUS) shown as part of the multimodality imaging capability on the Fujifilm CVIS.
The ILUMIEN IV and OCTOBER trials helped illustrate that the benefits of intravascular ultrasound also are seen with optical coherence tomography. Both trials were included in the new meta-analysis presented at ESC Congress 2023.
READ MORE >

FDA clears new smart scale capable of detecting AFib, other cardiovascular issues

The Body Scan Connected Health Station includes a high-strength glass platform with four weight sensors and 14 ITO electrodes and a retractable handle with four stainless steel electrodes.

READ MORE >
Withings Body Scan Connected Health Station FDA cleared
Share on Twitter Share on Facebook Share on Linkedin

FDA clears new smart scale capable of detecting AFib, other cardiovascular issues

Share on Twitter Share on Facebook Share on Linkedin
Withings Body Scan Connected Health Station FDA cleared
The Body Scan Connected Health Station includes a high-strength glass platform with four weight sensors and 14 ITO electrodes and a retractable handle with four stainless steel electrodes.
READ MORE >

Pulsed-field ablation as safe and effective as thermal ablation when treating paroxysmal AFib

Boston Scientific, which funded the study, hopes these results can help the company gain FDA approval for its PFA device in the months ahead. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Pulsed-field ablation as safe and effective as thermal ablation when treating paroxysmal AFib

Share on Twitter Share on Facebook Share on Linkedin
Boston Scientific, which funded the study, hopes these results can help the company gain FDA approval for its PFA device in the months ahead. 
READ MORE >

Featured Articles

Deferred testing for low-risk chest pain patients is safe, limits unnecessary catheterizations

Once physicians confirm a patient's CAD risk is low, they can feel comfortable putting diagnostic testing on hold. 

READ MORE >
patient_exam_cardiology_covid_dr_cowan_beaumont.jpeg
Share on Twitter Share on Facebook Share on Linkedin

Deferred testing for low-risk chest pain patients is safe, limits unnecessary catheterizations

Share on Twitter Share on Facebook Share on Linkedin
patient_exam_cardiology_covid_dr_cowan_beaumont.jpeg
Once physicians confirm a patient's CAD risk is low, they can feel comfortable putting diagnostic testing on hold. 
READ MORE >

Weight loss drug semaglutide linked to multiple benefits for heart failure patients

Researchers think their findings, which were presented at ESC Congress 2023 and published in the New England Journal of Medicine, could "change the nature of the conversation about the role of obesity in HFpEF."

READ MORE >
cardiologist doctor physician patient black diverse hypertension
Share on Twitter Share on Facebook Share on Linkedin

Weight loss drug semaglutide linked to multiple benefits for heart failure patients

Share on Twitter Share on Facebook Share on Linkedin
cardiologist doctor physician patient black diverse hypertension
Researchers think their findings, which were presented at ESC Congress 2023 and published in the New England Journal of Medicine, could "change the nature of the conversation about the role of obesity in HFpEF."
READ MORE >

Texas researchers receive $1.14M to develop first CVD drug of its kind

If successful, the group's first-in-class medication would be able to target inflammation in CVD patients before it even occurs. 

READ MORE >
A heart attack is caused when one of the coronary arteries becomes blocked with a clot.
Share on Twitter Share on Facebook Share on Linkedin

Texas researchers receive $1.14M to develop first CVD drug of its kind

Share on Twitter Share on Facebook Share on Linkedin
A heart attack is caused when one of the coronary arteries becomes blocked with a clot.
If successful, the group's first-in-class medication would be able to target inflammation in CVD patients before it even occurs. 
READ MORE >

In Case You Missed It

2 key reasons the use of AI in echocardiography is growing

Partho Sengupta, MD, an expert on the use of AI in cardiology, says some of the technologies being developed today will fundamentally change how cardiologists and sonographers do their jobs.

READ MORE >
Video of Partho Sengupta, MD, explaining two major shifts in AI for echocardiography at ASE 2023. These include GPT and deep learning to automate measurements. #ASE23 #ASE2023 #ASE #AI
Share on Twitter Share on Facebook Share on Linkedin

2 key reasons the use of AI in echocardiography is growing

Share on Twitter Share on Facebook Share on Linkedin
Video of Partho Sengupta, MD, explaining two major shifts in AI for echocardiography at ASE 2023. These include GPT and deep learning to automate measurements. #ASE23 #ASE2023 #ASE #AI
Partho Sengupta, MD, an expert on the use of AI in cardiology, says some of the technologies being developed today will fundamentally change how cardiologists and sonographers do their jobs.
READ MORE >

New TAVR valve, premounted to save cardiologists time, linked to promising 30-day outcomes

The new valve arrives fully premounted on a delivery system and was designed to allow resheathing or complete recapture/redeployment if necessary. 

READ MORE >
Vienna Aortic Self-Expandable Transcatheter Valve premounted on the delivery system
Share on Twitter Share on Facebook Share on Linkedin

New TAVR valve, premounted to save cardiologists time, linked to promising 30-day outcomes

Share on Twitter Share on Facebook Share on Linkedin
Vienna Aortic Self-Expandable Transcatheter Valve premounted on the delivery system
The new valve arrives fully premounted on a delivery system and was designed to allow resheathing or complete recapture/redeployment if necessary. 
READ MORE >

In Other News

Florida doctor pleads guilty to role in conspiracy to control cancer resources

“The FBI will not stand by and allow those trusted with saving lives to manipulate the healthcare system for their own benefit," one agent said in a DOJ statement. 

READ MORE >
Former managers of a Tampa Florida-based radiology company Advanced Diagnostic Group (ADG) and its employee stock ownership plan (ESOP) retirement benefit manager GreatBanc Trust Co. will pay $19 million to settle a class action lawsuit. The suit alleges they allowed the ESOP’s value to be diverted to managers, directors and their shell companies and away from employee participants. money gavel court lawsuit legal judge judgement
Share on Twitter Share on Facebook Share on Linkedin

Florida doctor pleads guilty to role in conspiracy to control cancer resources

Share on Twitter Share on Facebook Share on Linkedin
Former managers of a Tampa Florida-based radiology company Advanced Diagnostic Group (ADG) and its employee stock ownership plan (ESOP) retirement benefit manager GreatBanc Trust Co. will pay $19 million to settle a class action lawsuit. The suit alleges they allowed the ESOP’s value to be diverted to managers, directors and their shell companies and away from employee participants. money gavel court lawsuit legal judge judgement
“The FBI will not stand by and allow those trusted with saving lives to manipulate the healthcare system for their own benefit," one agent said in a DOJ statement. 
READ MORE >

Virtual radiology consultation services could add value—but are patients interested?

Patients appeared to show little interest in the offering, presenting an "important quandary" for the specialty, according to a new study. 

READ MORE >
Telehealth can provide significant value when it comes to managing and monitoring patients with CVD or suspected CVD. A new scientific statement from the American Heart Association explores the latest details on this evolving treatment option. 
Share on Twitter Share on Facebook Share on Linkedin

Virtual radiology consultation services could add value—but are patients interested?

Share on Twitter Share on Facebook Share on Linkedin
Telehealth can provide significant value when it comes to managing and monitoring patients with CVD or suspected CVD. A new scientific statement from the American Heart Association explores the latest details on this evolving treatment option. 
Patients appeared to show little interest in the offering, presenting an "important quandary" for the specialty, according to a new study. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup